Provided by Tiger Trade Technology Pte. Ltd.

Information

5.19
+0.12002.37%
Post-market: 5.190.0042+0.08%18:01 EDT
Volume:159.87K
Turnover:828.61K
Market Cap:251.27M
PE:21.64
High:5.21
Open:5.12
Low:5.09
Close:5.07
52wk High:6.45
52wk Low:3.74
Shares:48.41M
Float Shares:35.55M
Volume Ratio:0.94
T/O Rate:0.45%
Dividend:0.18
Dividend Rate:3.47%
EPS(TTM):0.2399
EPS(LYR):0.1900
ROE:12.30%
ROA:6.36%
PB:2.62
PE(LYR):27.32

Loading ...

Keymed’s CLDN18.2 Drug CMG901 Delivers Phase III Survival Gain in Gastric Cancer

TIPRANKS
·
Jul 28

3i Group plc (III) Receives a Sell from RBC Capital

TIPRANKS
·
Jul 28

Origin Energy CEO Says Information of Around 900,000 Current, Former Customers Accessed in Data Breach Incident

MT Newswires Live
·
Jul 28

Clinuvel maps SCENESSE’s path in vitiligo with new Phase III trial

TIPRANKS
·
Jul 28

Union Pacific, Norfolk Southern File Supplemental Information to STB on Merger

Dow Jones
·
Jul 28

Jiangsu Lopal Tech Calls EGM to Approve Indonesia Phase III Expansion

TIPRANKS
·
Jul 27

Arrowhead Finishes Patient Enrollment for Global Phase III YOSEMITE Trial of Zodasiran

Deep News
·
Jul 27

AstraZeneca's Sone-Ve Significantly Extends Overall Survival in Late-Stage Gastric Cancer Phase III Trial

Deep News
·
Jul 27

ISG Report Says US Public Agencies Shift Digital Workplace Focus to AI-driven Productivity

Reuters
·
Jul 27

OHB Pediatrics to go public through Research Alliance Corporation III pact

TIPRANKS
·
Jul 27

AstraZeneca says CLARITY-Gastric01 Phase III trial met dual primary endpoint

TIPRANKS
·
Jul 27

InnoCare's TYK2 Inhibitor Fadeucravacitinib (ICP-488) Meets Primary Endpoint in Phase III Psoriasis Study

GlobeNewswire
·
Jul 27

InnoCare’s Oral Psoriasis Drug ICP‑488 Hits Phase III Target, Paving Path to Regulatory Filing

TIPRANKS
·
Jul 27

Novartis: Balanced Upside Potential and Execution Risks Lead Analyst to Maintain Hold Rating Ahead of Key Phase III Readouts

TIPRANKS
·
Jul 27

Transcend Information Logs NT$20 Billion Profit in H1

MT Newswires Live
·
Jul 27

Inspur Electronic Information Industry Issues 1 Billion Yuan of Five-Year Bonds

MT Newswires Live
·
Jul 27

ASX Midday Sector Update: Information Technology Stocks Jump, Energy Sector Struggles

MT Newswires Live
·
Jul 27

Ipsen’s Bylvay misses Phase III goal in biliary atresia, limiting expansion bid

TIPRANKS
·
Jul 24

Biokin Pharma Enrolls First Subject in Phase III Clinical Trial of Breast Cancer Drug

MT Newswires Live
·
Jul 24

ASX Midday Sector Update: Energy Stocks Rise, Information Technology Sector Struggles

MT Newswires Live
·
Jul 24